These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 8863826

  • 1. Vasopressin V2 receptor mutants that cause X-linked nephrogenic diabetes insipidus: analysis of expression, processing, and function.
    Oksche A, Schülein R, Rutz C, Liebenhoff U, Dickson J, Müller H, Birnbaumer M, Rosenthal W.
    Mol Pharmacol; 1996 Oct; 50(4):820-8. PubMed ID: 8863826
    [Abstract] [Full Text] [Related]

  • 2. Characterization of vasopressin V2 receptor mutants in nephrogenic diabetes insipidus in a polarized cell model.
    Robben JH, Knoers NV, Deen PM.
    Am J Physiol Renal Physiol; 2005 Aug; 289(2):F265-72. PubMed ID: 16006591
    [Abstract] [Full Text] [Related]

  • 3. Functional rescue of mutant V2 vasopressin receptors causing nephrogenic diabetes insipidus by a co-expressed receptor polypeptide.
    Schoneberg T, Yun J, Wenkert D, Wess J.
    EMBO J; 1996 Mar 15; 15(6):1283-91. PubMed ID: 8635461
    [Abstract] [Full Text] [Related]

  • 4. Molecular genetic study of congenital nephrogenic diabetes insipidus and rescue of mutant vasopressin V2 receptor by chemical chaperones.
    Cheong HI, Cho HY, Park HW, Ha IS, Choi Y.
    Nephrology (Carlton); 2007 Apr 15; 12(2):113-7. PubMed ID: 17371330
    [Abstract] [Full Text] [Related]

  • 5. Binding-, intracellular transport-, and biosynthesis-defective mutants of vasopressin type 2 receptor in patients with X-linked nephrogenic diabetes insipidus.
    Tsukaguchi H, Matsubara H, Taketani S, Mori Y, Seido T, Inada M.
    J Clin Invest; 1995 Oct 15; 96(4):2043-50. PubMed ID: 7560098
    [Abstract] [Full Text] [Related]

  • 6. Mutations in the vasopressin V2 receptor gene in families with nephrogenic diabetes insipidus and functional expression of the Q-2 mutant.
    Rosenthal W, Seibold A, Antaramian A, Gilbert S, Birnbaumer M, Bichet DG, Arthus MF, Lonergan M.
    Cell Mol Biol (Noisy-le-grand); 1994 May 15; 40(3):429-36. PubMed ID: 7920187
    [Abstract] [Full Text] [Related]

  • 7. V2 vasopressin receptor dysfunction in nephrogenic diabetes insipidus caused by different molecular mechanisms.
    Schöneberg T, Schulz A, Biebermann H, Grüters A, Grimm T, Hübschmann K, Filler G, Gudermann T, Schultz G.
    Hum Mutat; 1998 May 15; 12(3):196-205. PubMed ID: 9711877
    [Abstract] [Full Text] [Related]

  • 8. [From genes to disease: from vasopressin-V2-receptor and aquaporine-2 to nephrogenic diabetes insipidus].
    Knoers NV, Deen PM.
    Ned Tijdschr Geneeskd; 2000 Dec 09; 144(50):2402-4. PubMed ID: 11145096
    [Abstract] [Full Text] [Related]

  • 9. An extracellular congenital nephrogenic diabetes insipidus mutation of the vasopressin receptor reduces cell surface expression, affinity for ligand, and coupling to the Gs/adenylyl cyclase system.
    Birnbaumer M, Gilbert S, Rosenthal W.
    Mol Endocrinol; 1994 Jul 09; 8(7):886-94. PubMed ID: 7984150
    [Abstract] [Full Text] [Related]

  • 10. An X-linked NDI mutation reveals a requirement for cell surface V2R expression.
    Sadeghi HM, Innamorati G, Birnbaumer M.
    Mol Endocrinol; 1997 Jun 09; 11(6):706-13. PubMed ID: 9171234
    [Abstract] [Full Text] [Related]

  • 11. Derlin-1 and p97/valosin-containing protein mediate the endoplasmic reticulum-associated degradation of human V2 vasopressin receptors.
    Schwieger I, Lautz K, Krause E, Rosenthal W, Wiesner B, Hermosilla R.
    Mol Pharmacol; 2008 Mar 09; 73(3):697-708. PubMed ID: 18048502
    [Abstract] [Full Text] [Related]

  • 12. Diverse vasopressin V2 receptor functionality underlying partial congenital nephrogenic diabetes insipidus.
    Faerch M, Christensen JH, Rittig S, Johansson JO, Gregersen N, de Zegher F, Corydon TJ.
    Am J Physiol Renal Physiol; 2009 Dec 09; 297(6):F1518-25. PubMed ID: 19812297
    [Abstract] [Full Text] [Related]

  • 13. Polarized expression of the vasopressin V2 receptor in Madin-Darby canine kidney cells.
    Andersen-Beckh B, Dehe M, Schülein R, Wiesner B, Rutz C, Liebenhoff U, Rosenthal W, Oksche A.
    Kidney Int; 1999 Aug 09; 56(2):517-27. PubMed ID: 10432391
    [Abstract] [Full Text] [Related]

  • 14. Cloning and characterization of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidus.
    Lolait SJ, O'Carroll AM, McBride OW, Konig M, Morel A, Brownstein MJ.
    Nature; 1992 May 28; 357(6376):336-9. PubMed ID: 1534150
    [Abstract] [Full Text] [Related]

  • 15. A fully active nonglycosylated V2 vasopressin receptor.
    Innamorati G, Sadeghi H, Birnbaumer M.
    Mol Pharmacol; 1996 Sep 28; 50(3):467-73. PubMed ID: 8794883
    [Abstract] [Full Text] [Related]

  • 16. Identification of mutations in the arginine vasopressin receptor 2 gene causing nephrogenic diabetes insipidus in Chinese patients.
    Chen CH, Chen WY, Liu HL, Liu TT, Tsou AP, Lin CY, Chao T, Qi Y, Hsiao KJ.
    J Hum Genet; 2002 Sep 28; 47(2):66-73. PubMed ID: 11916004
    [Abstract] [Full Text] [Related]

  • 17. Molecular pathogenesis of nephrogenic diabetes insipidus.
    Nguyen MK, Nielsen S, Kurtz I.
    Clin Exp Nephrol; 2003 Mar 28; 7(1):9-17. PubMed ID: 14586738
    [Abstract] [Full Text] [Related]

  • 18. Pharmacologic chaperones as a potential treatment for X-linked nephrogenic diabetes insipidus.
    Bernier V, Morello JP, Zarruk A, Debrand N, Salahpour A, Lonergan M, Arthus MF, Laperrière A, Brouard R, Bouvier M, Bichet DG.
    J Am Soc Nephrol; 2006 Jan 28; 17(1):232-43. PubMed ID: 16319185
    [Abstract] [Full Text] [Related]

  • 19. Functional rescue of vasopressin V2 receptor mutants in MDCK cells by pharmacochaperones: relevance to therapy of nephrogenic diabetes insipidus.
    Robben JH, Sze M, Knoers NV, Deen PM.
    Am J Physiol Renal Physiol; 2007 Jan 28; 292(1):F253-60. PubMed ID: 16926443
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.